TOSOH HLC-723G8 ANALYZER G8 021560

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional report with the FDA on 2019-02-14 for TOSOH HLC-723G8 ANALYZER G8 021560 manufactured by Tosoh Corporation.

Event Text Entries

[138252253] (b)(4) device evaluation by manufacturer: a field service engineer (fse) was dispatched to the customer's site to address the reported event. Fse confirmed complaint by observing the flow rate set to 1. 24. Fse replaced the check valve uptake. The customer successfully completed quality control (qc) run to validate instrument. No further action required by field service. The g8 instrument is functioning as expected. The check valve uptake was returned to tosoh instrument service center for investigation. Functional testing confirmed the reported fast retention time was due to partially occluded check valve uptake. A 13-month complaint history review and service history review for similar complaints was performed for the g8, serial number (b)(4) through aware date. There were no other similar complaints identified during the searched period. The g8 operator's manual under chapter 1, introduction and applications, states the following: the time from injection of the sample to the time the specific peak elutes off the column is called retention time. The tosoh automated glycohemoglobin analyzer hlc-723g8 software has been written so that each of the expected fractions has a window of acceptable retention times. If the designated peak falls within the expected window, the chromatogram peaks will be properly identified. When a peak elutes at a retention time not within a specified window, an unknown peak (p00) results. If more than one peak elutes at times not specified by the software windows, each is given a sequential p0x title. In order to keep the peaks within their appropriate windows, it may be necessary to change how fast or slow the buffers are moving through the system by changing the pump flow rate. The g8 variant analysis mode training manual under lesson 8 - troubleshooting, states the following: adjusting the flow rate - how and why: on the tosoh automated glycohemoglobin analyzer hlc-723g8; variant analysis mode it may be necessary to adjust the flow rate because either unidentifiable peaks appear on all the chromatograms or the average retention time for various peaks has changed significantly. The flow rate is changed by changing the flow factor in the instrument. The flow factor is generally 1. 00 ml/min. The flow factor should only be adjusted +/- 0. 05 of the default factory setting. The most probable cause of the fast retention time was due to the failure of the check valve uptake.
Patient Sequence No: 1, Text Type: N, H10


[138252254] A customer reported seeing fast sa1c retention time (rt) (acceptable range is 0. 57 to 0. 61 minutes) on patient samples with the g8 instrument. The technical support specialist (tss) advised the customer to adjust the flow factor from 1. 18 ml/min to 1. 21 ml/min in order to adjust the retention time to acceptable range of 0. 57 to 0. 61 minutes. Customer was also advised to power off and on instrument, then prime instrument with five samples run, calibrate and run quality controls (qc), then run patient samples. Customer followed up and stated, rt is still high on qc and p00 flag occurred. Tss advised the customer to adjust the flow factor again from 1. 21 ml/min to 1. 23 ml/min, then calibrate and run qc. The run completed with still fast rt at 0. 62. Customer was advised to adjust the flow rate again, and the sa1c rt was 0. 59 which is within acceptable range. The sa1c rt remained in range for several days, but customer later reported the sa1c rt is still drifting. A field service engineer (fse) was dispatched to address the reported event, which resulted in delay in reporting of patient results for hemoglobin a1c (hba1c). There was no indication of any patient intervention or adverse health consequences due to the delay in reporting of patient results.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number8031673-2019-00024
MDR Report Key8341370
Report SourceHEALTH PROFESSIONAL
Date Received2019-02-14
Date of Report2019-02-14
Date of Event2018-12-27
Date Facility Aware2018-12-27
Report Date2019-02-14
Date Reported to FDA2019-02-14
Date Reported to Mfgr2019-02-14
Date Mfgr Received2018-12-27
Device Manufacturer Date2013-06-01
Date Added to Maude2019-02-14
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. DORIA ESQUIVEL
Manufacturer Street6000 SHORELINE COURT SUITE 101
Manufacturer CitySOUTH SAN FRANCISCO CA 94080
Manufacturer CountryUS
Manufacturer Postal94080
Manufacturer Phone6509368123
Manufacturer G1TOSOH CORPORATION (MANUFACTURER)
Manufacturer StreetSHIBA-KOEN FIRST BUILDING 3-8-2 SHIBA
Manufacturer CityMINATO-KU, TOKYO, JAPAN 1058623
Manufacturer CountryJA
Manufacturer Postal Code1058623
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameTOSOH HLC-723G8 ANALYZER G8
Generic NameG8
Product CodeLCP
Date Received2019-02-14
Returned To Mfg2019-01-22
Model NumberG8
Catalog Number021560
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device Age5 YR
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerTOSOH CORPORATION
Manufacturer AddressSHIBA-KOEN FIRST BUILDING 3-8-2 SHIBA MINATO-KU, TOKYO, JAPAN 1058623 JA 1058623


Patients

Patient NumberTreatmentOutcomeDate
10 2019-02-14

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.